Arrowhead Pharmaceuticals (ARWR)
2.11
+0.10 +4.98%
NASDAQ
Aug 18, 16:59
Delayed 2m
USD
View All Key Stats
ARWR Key Stats
| Income Statement | |
| Revenue (TTM) | 22.73M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.66 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -45.87M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -59.08% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 157.77M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.633 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.751 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.0287 |
| Free Cash Flow (Quarterly) | -11.57M |
| Return on Equity (TTM) | -52.45% |
View All ARWR News
ARWR News
-
WireHeadlineTime (ET)
-
SA Breaking News08/18 11:01
-
PR Newswire08/16 06:35
-
Yahoo08/13 20:31
-
Yahoo08/08 08:10
-
MT Newswires08/03 17:59
-
MT Newswires08/03 16:13
-
Business Wire08/03 16:00
-
Yahoo08/03 11:50
-
Business Wire07/27 16:00
-
Yahoo07/10 13:59
View All Events
ARWR Events
| Date | Type | Description |
|---|---|---|
| 08/03/2017 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Arrowhead Pharmaceuticals Inc Third Quarter Earnings in 2017 Release |
| 05/03/2017 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
| 05/03/2017 | Earnings | Arrowhead Pharmaceuticals Inc Second Quarter Earnings in 2017 Release |
| 03/21/2017 | Misc | Arrowhead Pharmaceuticals Inc Annual General Meeting in 2016 |
| 02/06/2017 16:30 EST | Misc | Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call in 2017 |
| 02/06/2017 | Earnings | Arrowhead Pharmaceuticals Inc First Quarter Earnings in 2017 Release |
| 12/14/2016 16:30 EDT | Misc | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2016 |
| 12/14/2016 | Earnings | Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings in 2016 Release |
| 09/29/2016 06:00 PDT | Misc | Session: Parallel 19: Pediatric and Metabolic Liver Diseases: Basic and Translational |
ARWR Fundamentals
Income Statement View Statement
ARWR Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ARWR One Page Reports
- One Page Report Download
ARWR Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 2.11 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.arrowheadpharma.com
- Investor Relations URL: http://ir.arrowheadpharma.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins.
ARWR Comparables
EditARWR Excel Add-In Codes
- Name: =YCI("ARWR","name")
- Description: =YCI("ARWR","description")
- Sector: =YCI("ARWR","sector")
- Industry: =YCI("ARWR","industry")
- Est. Current Fiscal Year End: =YCI("ARWR","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ARWR Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ARWR Tweets Stocktwits
Advertisement
